4. Healthcare industry's capacity will get better

Deloitte expects healthcare and life science companies to enhance their investment in setting up more regional distribution centers and adding cold chain delivery, in order to bring down costs to prepare for the next round of competition.

Quality control will serve a pivotal role, according to the report, as the market participants need to enhance their service scope with a reasonable cost level while upholding the overall quality.

Employees of Ottobock, a manufacturer of orthopaedic technology, works on a prosthetic device at a production plant in Bejing, Nov 13, 2014. [Photo/IC]